Medically reviewed by Dr Eric Wang- ChinaCureLink Team
Hainan Boao Lecheng hospitals are separate medical institutions within a medical tourism pilot zone in Qionghai, Hainan. Ruijin Hainan Hospital, Boao Super Hospital and Shulan (Boao) Hospital are three options to compare by diagnosis, receiving specialist and the treatment being considered. The zone is not one hospital, and its special policies do not make every treatment available to every patient.
For international patients, Lecheng’s distinctive feature is a regulated pathway for certain medicines and devices already approved overseas but not yet registered in mainland China. Hospital assessment, product-specific permission and safe follow-up still matter. This guide explains those distinctions, compares three institutions and six specialist profiles, and sets out a practical route before you travel.
Key Takeaways |
|
Table of Contents
How the Boao Lecheng Hospital System Works
The Boao Lecheng International Medical Tourism Pilot Zone was approved in 2013 and is located in Qionghai, on Hainan Island. It brings together hospitals, specialist platforms and research activity. A zone-level announcement about an innovative product does not establish that every hospital stocks it or can prescribe it.
Start with your diagnosis and the clinical question. Someone seeking a pancreatic assessment needs a different team from someone seeking glaucoma surgery, a hematology opinion or management of a chronic condition. A hospital’s brand, a visiting expert’s reputation and the receiving department’s actual service should be considered separately.
The three institutions below are a practical shortlist, not a ranking based on clinical outcomes. This is not an exhaustive directory of all Lecheng providers. Our China hospital comparison guide explains how to assess institutions and services.
On a smaller screen, swipe the table horizontally to view every column.
Hospital | Reasons to Compare It | Confirm Before Booking |
|---|---|---|
Ruijin Hainan Hospital | Public research hospital linked to Shanghai Ruijin; multidisciplinary care and special-access projects | Relevant department, Hainan clinic availability, proposed treatment and current product permissions |
Boao Super Hospital | Shared hospital platform with specialist teams; documented eye-care and real-world research experience | Specific center and clinician, operating institution, clinic dates and follow-up arrangements |
Shulan (Boao) Hospital | Shulan group hospital with general surgery, oncology and chronic-disease services | Receiving clinical center, named team, treatment scope and itemized costs |
Special Access and Clinical Evidence
Special access is a regulated route for a defined clinical need. Hainan’s published rules describe designated institutions using certain overseas-approved drugs that are not registered in China and cannot be replaced by available domestic products, and certain overseas-approved devices without an equivalent registered domestic product. The drug definition in those rules excludes vaccines. This is not general permission to import any treatment.
The rules require disclosure and informed consent, use for the designated medical purpose, clinical records and safety monitoring. Permission to take a product away depends on assessment and applicable controls. It does not establish permission to import it into your home country. Check the exact current authorization, indication and receiving institution before planning around a named product.
A September 2026 single-center Hainan glaucoma report illustrates the evidence involved. It enrolled 59 patients receiving a gel stent; 59 eyes were analyzed for effectiveness and 62 implanted eyes for safety. At 12 months, average eye pressure fell from 23.7 to 17.4 mmHg, while average pressure-lowering medication use fell from 3.3 to 1.0.
In the observed-data analysis, 49.0% met the defined effectiveness endpoint: at least 20% pressure reduction without more medication or secondary surgery. Serious ocular adverse events were recorded in 17 of 62 implanted eyes, including pressure increases and device problems. The study had no comparator and was industry sponsored. These results do not prove superiority or restoration of lost sight.
The paper describes historical Lecheng data supporting later Chinese registration of this stent. That is different from saying it remains available only through special access today. A clinical trial, special-access treatment and a nationally registered product are different pathways; ask which applies to the proposal you receive.
Pathway or Evidence | Verified Point | Meaning for Your Decision |
|---|---|---|
Lecheng clinical-need import rules | Certain overseas-approved products may be used by designated institutions for specific medical purposes | Confirm the exact current authorization and indication; this is separate from nationwide registration |
Hainan gel-stent study; 2026 | 59 effectiveness eyes; 49.0% met the 12-month endpoint in observed-data analysis; serious ocular events in 17/62 implanted eyes | No comparator and industry sponsorship; discuss risks, alternatives and follow-up rather than assuming superiority |
Which Hospital Fits Your Care Needs?
Eligibility depends on condition, medical history and treatment goals. Send your records and we’ll match you with relevant Chinese hospitals and specialists at no cost.
Free matching · Paid video specialist consultations · Fees confirmed before booking
Planning Care From Overseas
Send the receiving team a concise history, diagnosis, medicines and allergies, previous treatments, laboratory results, imaging reports and original DICOM files. Include pathology and molecular results where relevant. Ask what requires translation and whether the records are sufficient for an initial specialist review.
Obtain written case acceptance and the exact institution, center and clinician responsible for care. Specialist platforms may use visiting teams, so a prominent doctor’s association does not guarantee a clinic slot or that the named doctor will perform a procedure. Confirm medical interpretation and consent arrangements rather than assuming an English website means every service operates in English.
If an imported medicine or device is proposed, request its generic and brand name, indication, approval pathway, availability and anticipated monitoring. Ask why it is being considered over established alternatives. “Innovative” and “available earlier” describe access or timing, not proof of better outcomes for your case.
Get an itemized estimate covering assessment, tests, medicines or devices, procedures, admission and interpretation or coordination fees. Confirm deposits, cancellations and possible additional treatment. Insurance coverage depends on the policy and product; domestic insurance eligibility does not establish overseas coverage. No standard all-inclusive price can be inferred from zone policy.
Plan travel after the clinical schedule is clear, allowing time for further assessment and recovery. Our medical trip planning guide and China medical tourism guide cover records, travel and care continuity.
How ChinaCureLink Helps You Compare the Options
ChinaCureLink helps organize the diagnosis, records and treatment history for review and matches a case with up to three appropriate hospitals or specialists. For Lecheng inquiries, the useful starting point is the clinical need and exact treatment under consideration, rather than a promise of access to an overseas product. The receiving doctor determines clinical suitability.
Hospital and specialist matching is free. Optional specialist video second opinions are paid, with fees confirmed before booking. If you proceed, later coordination may include appointments, records, interpretation arrangements, travel and follow-up; confirm the scope and price in writing. The hospital and specialist matching guide explains the process.
Three Hospitals and Six Specialist Profiles
These profiles illustrate different clinical routes and do not rank individual doctors. Some experts work through shared or visiting-team arrangements. Confirm the current Hainan clinic, the clinician assigned to your case and the operating institution. Consultation buttons send an inquiry and do not reserve an appointment.
1. Ruijin Hainan Hospital
The full institutional name is Hainan Hospital of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine; it is also known as Boao Research Hospital. It began trial operations in December 2021 and was approved as a national regional medical center construction project in 2022.
Its described clinical focus includes oncology and hematology, cardiovascular and metabolic conditions, and neurological care. For a patient, the important question is which relevant department can assess the case and coordinate investigations or treatment locally.
The Hainan campus is a distinct destination from Shanghai Ruijin. Confirm where consultations, tests and any procedure will take place, which specialists will be present and whether a proposed special-access product is currently authorized and available. The pancreatic diagnostic report below illustrates collaboration, rather than a guarantee of identical access to every Shanghai service.
Qionghai · Boao Lecheng · Confirm Receiving Clinic · Public Research Hospital · National Regional Medical Center Project
Shanghai Ruijin clinical links · Multidisciplinary care · Special-access projects
Known for: A public research-hospital model connected with Shanghai Ruijin expertise.
2. Boao Super Hospital
Boao Super Hospital began operating in March 2018. The Lecheng Real-World Research Institute describes its “1+X” model as one shared hospital platform with multiple expert-led specialties. This makes the particular clinical center and responsible team important parts of the booking decision.
Its documented services include several medical and surgical specialties, with eye-care collaborations providing a clear example of special-access and research activity. The Hainan gel-stent study discussed above lists Boao Super Hospital affiliations. It is evidence about a specific procedure in selected patients, not a general hospital success rate.
For an eye-care inquiry, clarify the center’s operating identity, local and visiting specialists, the exact procedure and postoperative follow-up. The Wenzhou-linked experts below have documented involvement in the Boao eye-care platform and research; their inclusion does not imply daily residence, immediate availability or that either will personally operate.
Qionghai · Boao Lecheng · Confirm Specialist Center · State-Controlled General Hospital · Shared Specialist Platform
Shared specialist platform · Eye-care teams · Real-world research
Known for: A shared-hospital platform linking specialist teams and clinical innovation projects.
3. Shulan (Boao) Hospital
Shulan (Boao) Hospital belongs to Shulan Medical Group and describes a shared-platform model with several clinical centers. Its institutional introduction lists general and hepatobiliary surgery, oncology, infectious disease, renal, respiratory and digestive services among its disciplines.
The hospital describes planning and construction to Grade III Class A standards. That statement should not be treated as proof of a current formal accreditation. For an international patient, the practical comparison is the receiving center’s experience with the diagnosis, its proposed care plan and the arrangements for ongoing management.
The two surgical profiles below are relevant examples for liver, biliary and pancreatic disease. Patients with other conditions should be directed to the appropriate service. Obtain confirmation of the responsible clinician, visiting-team schedule where applicable, alternatives and costs; a group affiliation does not establish that every treatment is offered at every campus.
Qionghai · Boao Lecheng · Confirm Clinical Center · Shulan Group General Hospital · Verify Current Accreditation Separately
General and hepatobiliary surgery · Oncology services · Chronic-disease care
Known for: A shared clinical-center model with surgical and chronic-disease services.
A Recent Ruijin Hainan Diagnostic Case
A September 2025 hospital-linked report described a 26-year-old man from Guangxi with a pancreatic mass and uncertain earlier assessments. At Ruijin Hainan, a multidisciplinary team reviewed imaging and arranged endoscopic ultrasound-guided tissue sampling with support from Shanghai Ruijin specialists.
The report states that pathology identified a solid pseudopapillary tumor. Following discussion, the patient chose scheduled follow-up, with possible surgery if later required. This was a diagnostic report, not evidence that the tumor had been cured; it did not provide long-term comparative outcomes.
The practical lesson is that access to a new product is not always the first priority. Establishing the diagnosis and reviewing options can change the plan. This individual management choice should not be generalized to other pancreatic masses or used as advice to postpone indicated treatment.
Arranging Follow-Up Beyond Hainan
Before treatment, agree who will monitor your condition after you return home, which tests are needed and how complications will be handled. Eye surgery may require repeated pressure and wound checks; systemic medicines may require laboratory monitoring. Confirm which services your local clinician can provide and how the Hainan team will share records.
Obtain discharge or consultation notes, medicine names and doses, imaging, pathology and a written follow-up schedule. For an imported product, clarify supply continuity, permitted quantities, storage and travel documentation with the hospital and relevant authorities. A prescription or take-away authorization in Hainan does not automatically permit entry into another country.
You Contact the Hospital vs. via ChinaCureLink
Both routes can work. Many large Chinese hospitals have international departments, and some patients go direct. Here is what each route looks like, step by step.
Swipe the table horizontally on smaller screens to view all columns.
What to Arrange | Contacting Hospitals Yourself | With ChinaCureLink |
|---|---|---|
Hospital and specialist choice | Research and contact suitable teams yourself | ✓ Diagnosis-based hospital and specialist matching — free |
Appointments | Arrange times and follow up with each team | ✓ Support with scheduling and hospital communication |
Medical records | Prepare and translate the required documents | ✓ Help organizing records for specialist review |
Language assistance | Check the hospital’s interpreter arrangements | ✓ Help arranging interpretation for medical discussions |
Travel and accommodation | Book your travel and stay independently | ✓ Coordination after you choose to proceed |
Local coordination | Check what support the hospital offers | ✓ Coordinator support during your stay |
Continuing care | Request records and arrange follow-up yourself | ✓ Help coordinating records for your home doctor |
Hospital quote | Ask the hospital for an itemized estimate | ✓ Help obtaining the quote and applying for an international discount, where available |
Hospital and specialist matching is free. Specialist video consultations and later on-site services have separate fees, confirmed before booking. Any hospital discount depends on the hospital and individual quotation.
Start With Free Hospital and Specialist Matching
ChinaCureLink represents patients, not hospitals. Hospital and specialist matching is free, and travel coordination begins only after you choose to proceed.
Free matching · Paid video specialist consultations · Fees confirmed before booking
Next step: Obtain a diagnosis-matched assessment, compare the written recommendations and confirm costs and follow-up before making travel arrangements.
Get a Second Opinion
For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.
Hospital and specialist matching is free. Video second opinions are paid specialist consultations, with fees confirmed before booking.
What Patients Say About ChinaCureLink & Medebound HEALTH

China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.
Frequently Asked Questions
Which Hainan Boao Lecheng hospitals should international patients compare?
Ruijin Hainan Hospital, Boao Super Hospital and Shulan (Boao) Hospital are three options to compare by diagnosis and receiving specialty. Lecheng contains separate providers, and this shortlist is not a clinical-outcome ranking or an exhaustive directory. Confirm the relevant center, clinician, language support and costs.
Can I receive a medicine in Lecheng before it is registered in mainland China?
Some overseas-approved medicines and devices can be used through a regulated clinical-need pathway at designated institutions. Access depends on the exact product, authorization, indication and clinical assessment. It is not blanket permission for every imported treatment and is separate from clinical-trial participation.
Can I take a Lecheng medicine home after treatment?
Hainan’s rules allow certain products to be taken away for personal use after assessment and subject to applicable controls. Permission is product-specific and does not establish permission to import it into another country. Confirm quantities, monitoring, storage, supply and destination-country requirements before travel.
Talk It Through Before You Decide
Start with free hospital and specialist matching. We’ll review your situation and match you with relevant hospitals and specialists at no cost. Paid video second opinions are available, with fees confirmed before booking.
Free matching · Paid video specialist consultations · Fees confirmed before booking
About ChinaCureLink
ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.
ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.
References
Disclaimer
This article is for informational purposes only and is not medical or financial advice. Treatment eligibility, protocols, and costs vary by individual case — confirm specifics with a coordinator and treating physician before making any decisions.
You may also like:
